கொழுமியம் மேலாண்மை நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கொழுமியம் மேலாண்மை நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கொழுமியம் மேலாண்மை நிறுவனம் Today - Breaking & Trending Today

ESPERION Appoints JoAnne Mical - GuruFocus.com


Confirm
– Expansion of management team with proven leader in cardiovascular disease supports advancement of CLEAR Outcomes trial and ESPERION therapeutic pipeline –
ANN ARBOR, Mich., June 28, 2021 (GLOBE NEWSWIRE) ESPERION ( ESPR), today announced the appointment of JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer, effective immediately. She will serve as a member of the executive team and report to Sheldon Koenig, President and Chief Executive Officer. Dr. Foody brings more than 20 years of experience in academic and preventive cardiology to ESPERION.
“Dr. Foody is a global expert with extensive clinical and medical experience in preventive cardiology, global medical development and medical affairs, which adds greatly to the depth of our management team,” said Sheldon Koenig, President and Chief Executive Officer of ESPERION. “JoAnne joins ESPERION at a critical period for the Company as we continue to drive towards the completion of our landma ....

United States , Joanne Micale Foody , Sheldon Koenig , Janssen Pharmaceutical Company , American Heart Association , Ben Church , Lipid Management Company , Cardiovascular Medical Affairs For Janssen , Merck Research Labs , University Of Chicago , Development Team Leader For Janssen Xarelto , Head Of Data Sciences For Cardiovascular , American College Of Cardiology , Princeton University , Cleveland Clinic Foundation In , Exchange Commission , Pritzker School Of Medicine , Scientific Affairs , Chief Medical Officer , Chief Executive , Chief Executive Officer , Vice President , Data Sciences , Metabolism Pulmonary Hypertension , Compound Development Team Leader , Cardiovascular Medical Affairs ,

ESPERION Appoints Sheldon Koenig as President and CEO


ESPERION Appoints Sheldon Koenig as President and CEO
May 17, 2021 09:01 ET
| Source:
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
Ann Arbor, Michigan, UNITED STATES
Mr. Koenig has 30 years of commercial and operational experience as an accomplished leader in the cardiovascular space; 
previously served as ESPERION COO
Succeeds Tim Mayleben, who served as President and CEO for almost a decade and will continue to serve as a senior advisor –
ANN ARBOR, Mich., May 17, 2021 (GLOBE NEWSWIRE) ESPERION (NASDAQ: ESPR), today announced the appointment of Sheldon Koenig as president and chief executive officer and board member, effective immediately. With over 30 years of commercial and operational experience as an accomplished leader in the cardiovascular space, Mr. Koenig has served as the company’s chief operating officer since December 2020. He is succeeding Tim Mayleben, who a ....

Nicole Vitullo , Tim Mayleben , Sheldon Koenig , Drexel University , Alexion Pharmaceuticals , Ben Church , Monmouth University , Lipid Management Company , Portola Pharmaceuticals , Exchange Commission , Wharton School , Lipid Management , Nasdaq Espr , Esperion Therapeutics , ஷெல்டன் க்க்நிக் , ட்ரெக்செல் பல்கலைக்கழகம் , அலெக்சியன் மருந்துகள் , பென் தேவாலயம் , மோன்மவுத் பல்கலைக்கழகம் , கொழுமியம் மேலாண்மை நிறுவனம் , போர்த்தோழ மருந்துகள் , பரிமாற்றம் தரகு , வார்டன் பள்ளி , கொழுமியம் மேலாண்மை ,

Simulation Model based on Pooled Phase 3 Data Demonstrating


Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21
May 15, 2021 12:00 ET
| Source:
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
Ann Arbor, Michigan, UNITED STATES
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction in 10-year cardiovascular event risk compared with statins alone (p ....

United States , United Kingdom , City Of , Kaitlyn Brosco , Gunn Laura , Daiichi Sankyo Europe , Nicholls Stephen , Laurah Gunn , Honorary Research , University Of North Carolina At Charlotte , American College Of Cardiology , Department Of Public Health Sciences , School Of Public Health , Lipid Management Company , Exchange Commission , Imperial College London , European Medicines Agency , Heart British Cardiac Society , School Of Data Science , Second Manifestations , Cholesterol Treatment Trialist , American College , Annual Scientific Session , Cardiovascular Benefits , Bempedoic Acid , Patients With Established Cardiovascular Disease ,